Hence, we were interested to establish the outcome of challenge with a biologically distinct virus, particularly to challenge with macrophage-tropic strains with reduced CD4-dependence for cell entry in vitro and a distinct pattern of cell distribution following infection in vivo and whether this would impact on characterized neuropathological outcomes. The gene discussed is CD4; the disease is infection.